CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, in human myeloid malignancies, including AML, chronic myeloid leukemia, and particularly mast cell leukemia, the leukemia-initiating cells are considered to occupy the CD34-positive subpopulation of the malignant clone [33–35].